Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non‐appendiceal peritoneal carcinomatosis from a prospective database

Abstract

The morbidity and mortality rates after the combined treatment for non-appendiceal peritoneal carcinomatosis were within the acceptable range of surgical treatments for other gastrointestinal cancers. A standardized prospective database is required for an accurate assessment of perioperative outcomes.